Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 17, 2025 09:00 ET | Source: Airway Management, Inc.

Nylon flexTAP®: First FDA cleared 3D-Printed Midline Oral Appliance for Sleep Apnea

Airway Management proudly announces FDA clearance of Nylon flexTAP®, the world’s first digitally printed single-point midline oral appliance device for OSA
July 16, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Obstructive Sleep Apnea Clinical Trial Pipeline Expands as 12+ Companies Driving Innovation in OSA Therapeutics | DelveInsight

New York, USA, July 16, 2025 (GLOBE NEWSWIRE) -- Obstructive Sleep Apnea Clinical Trial Pipeline Expands as 12+ Companies Driving Innovation in OSA Therapeutics | DelveInsight The obstructive sleep...
June 12, 2025 07:30 ET | Source: Incannex Healthcare

Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution

NEW YORK and MELBOURNE, Australia, June 12, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing...
June 03, 2025 07:30 ET | Source: Incannex Healthcare

Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program

NEW YORK and MELBOURNE, Australia, June 03, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company leading the way...
May 29, 2025 07:30 ET | Source: Incannex Healthcare

Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance

NEW YORK and MELBOURNE, Australia, May 29, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage pharmaceutical company developing novel combination therapies, today...
May 28, 2025 07:00 ET | Source: Incannex Healthcare

Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results

MELBOURNE, Australia and NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company advancing combination drug therapies for...
August 07, 2024 17:30 ET | Source: ProSomnus Sleep Technologies, Inc.

ProSomnus® Sleep Technologies Announces Record Revenues as it Emerges from Reorganization

ProSomnus® Sleep Technologies Announces Record Revenues as it Emerges from Reorganization
May 30, 2024 06:00 ET | Source: ProSomnus Sleep Technologies, Inc.

ProSomnus Contributes Two Scientific Abstracts for Presentation at SLEEP 2024, A Joint Meeting of the American Academy of Sleep Medicine and the Sleep Research Society

ProSomnus Contributes Two Scientific Abstracts for Presentation at SLEEP 2024
May 13, 2024 09:00 ET | Source: ProSomnus Sleep Technologies, Inc.

ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting

ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting
May 09, 2024 18:30 ET | Source: ProSomnus Sleep Technologies, Inc.

Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices

Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices